Role Summary
The Strategy & Growth Enterprise Portfolio Insights team is seeking a Director, Product Commercial Assessment & Insights (PCAI). This role will assess and generate transparent, evidence-based long-term revenue assessments for the therapeutic area portfolio, pipeline, and marketed products of Novartis. Responsibilities include leading or updating long-term forecast updates for new and existing programs and providing opportunity assessments. The Director will synthesize key risks and opportunities in commercial assessments across programs and the Therapy Area/portfolio level and will work within one of four therapeutic areas (cardiovascular, immunology, neurology, or oncology).
Responsibilities
- Has a deep understanding and hands-on experience directly supporting and leading forecasting, new product planning & commercial assessments with at least one therapeutic area expertise (cardiovascular, immunology, neurology, or oncology)
- Able to synthesize key insights and clear communicate features of market opportunity assessments, patient journey mapping, HCP/patient insights, competitive intelligence, and positioning strategies to determine clear risks and opportunities for a specific program
- Has the ability to synthesize complex data into constructing clear and simple narratives and strategic recommendations for senior leadership through impactful presentations and visualizations.
- Develops and maintains indication-specific and epidemiology-based sales and volume forecasts for pipeline and in-market brands on both an as needed and evolving basis for a designated therapeutic area.
- Works collaboratively with the Strategy & Growth (S&G), US, and International (INT) teams, as well as other cross-functional partners, to ensure product and market insights are integrated into forecasts, and that US & INT numbers are then rolled into a single set of approved brand numbers
- Coordinates with and obtains alignment from key stakeholders, including US & INT, on critical assumptions and generating and aligning on the treatment journey.
- Consolidates and summarizes sales forecast assumptions, methodology, and results to all relevant stakeholders, systems and platforms
- Works on an as needed basis on supporting forecast development and insight generation for licensing and M&A opportunities under guidance of C&BD colleagues within S&G
- Coaches and mentors junior colleagues
Qualifications
- Required: Fluent in oral and written English; other language(s) are an added bonus
- Required: Minimum 10 years of experience in Biotech/Pharmaceutical industry, life sciences consulting with commercial assessment experience; in-market commercial, finance, and/or new product planning experience.
- Preferred: Familiarity with epidemiology sources, IQVIA, Evaluate Pharma, claims, and other standard pharmaceutical databases
- Preferred: Experience incorporating big data analytics, competitive intelligence, primary & secondary market research into forecast models
- Preferred: Comfortable with identifying and implementing AI solutions where appropriate
- Required: Strong understanding of forecast methodologies, including expertise in patient-based forecast modelling
- Required: Expertise in translating inputs from cross-functional business partners into commercial forecast models
- Required: Demonstrated ability to work independently with minimal direction
- Preferred: Strong project management skills, with the ability to manage multiple projects simultaneously
- Preferred: Effective team building and consulting skills, with demonstrated ability to work collaboratively in cross-functional teams
- Required: Excellent written, verbal, and presentation skills
Education
- Bachelorβs degree required; MBA or advanced degree strongly preferred.